| Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study L Kappos, A Bar-Or, BAC Cree, RJ Fox, G Giovannoni, R Gold, ... The Lancet 391 (10127), 1263-1273, 2018 | 949 | 2018 |
| Linezolid-induced inhibition of mitochondrial protein synthesis AS De Vriese, R Van Coster, J Smet, S Seneca, A Lovering, LL Van Haute, ... Clinical infectious diseases 42 (8), 1111-1117, 2006 | 303 | 2006 |
| Vascular aspects of multiple sclerosis M D'haeseleer, M Cambron, L Vanopdenbosch, J De Keyser The Lancet Neurology 10 (7), 657-666, 2011 | 288 | 2011 |
| Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial D Cadavid, L Balcer, S Galetta, O Aktas, T Ziemssen, L Vanopdenbosch, ... The Lancet Neurology 16 (3), 189-199, 2017 | 258 | 2017 |
| Effects of vascular endothelial growth factor (VEGF) on motor neuron degeneration L Van Den Bosch, E Storkebaum, V Vleminckx, L Moons, ... Neurobiology of disease 17 (1), 21-28, 2004 | 144 | 2004 |
| The G93C mutation in superoxide dismutase 1: clinicopathologic phenotype and prognosis L Régal, L Vanopdenbosch, P Tilkin, L Van Den Bosch, V Thijs, R Sciot, ... Archives of neurology 63 (2), 262-267, 2006 | 93 | 2006 |
| Mitochondrial mutations of Leber's hereditary optic neuropathy: a risk factor for multiple sclerosis L Vanopdenbosch, B Dubois, MB D'Hooghe, F Meire, H Carton Journal of neurology 247, 535-543, 2000 | 86 | 2000 |
| Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study CE Leurs, HAM Twaalfhoven, BI Lissenberg-Witte, V Van Pesch, ... Multiple Sclerosis Journal 26 (8), 912-923, 2020 | 79 | 2020 |
| Relapsing meningitis caused by persistent cryptococcal antigens and immune reconstitution after the initiation of highly active antiretroviral therapy JR Boelaert, KH Goddeeris, LJ Vanopdenbosch, JW Casselman Aids 18 (8), 1223-1224, 2004 | 69 | 2004 |
| Diffusion-weighted magnetic resonance imaging in Creutzfeldt-Jakob disease P Demaerel, AL Baert, L Vanopdenbosch, W Robberecht, R Dom The Lancet 349 (9055), 847-848, 1997 | 63 | 1997 |
| Corticosteroids in the management of acute multiple sclerosis exacerbations I Smets, L Van Deun, C Bohyn, V Van Pesch, L Vanopdenbosch, D Dive, ... Acta Neurologica Belgica 117, 623-633, 2017 | 59 | 2017 |
| NEK1 genetic variability in a Belgian cohort of ALS and ALS-FTD patients HP Nguyen, S Van Mossevelde, L Dillen, JL De Bleecker, M Moisse, ... Neurobiology of aging 61, 255. e1-255. e7, 2018 | 43 | 2018 |
| MRI with intrathecal gadolinium to detect a CSF leak: a prospective open-label cohort study LJ Vanopdenbosch, P Dedeken, JW Casselman, SAPA Vlaminck Journal of Neurology, Neurosurgery & Psychiatry 82 (4), 456-458, 2011 | 38 | 2011 |
| Association of cerebral venous thrombosis and intracranial hypotension: review of 3 cases L Sinnaeve, L Vanopdenbosch, K Paemeleire Journal of Stroke and Cerebrovascular Diseases 26 (8), e165-e169, 2017 | 29 | 2017 |
| Anti-glycine receptor antibody mediated progressive encephalomyelitis with rigidity and myoclonus associated with breast cancer SN De Blauwe, P Santens, LJ Vanopdenbosch Case reports in neurological medicine 2013, 2013 | 27 | 2013 |
| Fluoxetine in progressive multiple sclerosis (FLUOX-PMS): study protocol for a randomized controlled trial M Cambron, J Mostert, P Haentjens, M D’Hooghe, G Nagels, B Willekens, ... Trials 15, 1-7, 2014 | 25 | 2014 |
| Bell’s palsy with ipsilateral numbness LJ Vanopdenbosch, K Verhoeven, JW Casselman Journal of Neurology, Neurosurgery & Psychiatry 76 (7), 1017-1018, 2005 | 25 | 2005 |
| Shorter infusion time of ocrelizumab: results from the randomized, double-blind ENSEMBLE PLUS substudy in patients with relapsing-remitting multiple sclerosis HP Hartung, T Berger, RA Bermel, B Brochet, WM Carroll, T Holmøy, ... Multiple sclerosis and related disorders 46, 102492, 2020 | 24 | 2020 |
| Predictors of response to opicinumab in acute optic neuritis D Cadavid, L Balcer, S Galetta, O Aktas, T Ziemssen, LJ Vanopdenbosch, ... Annals of Clinical and Translational Neurology 5 (10), 1154-1162, 2018 | 24 | 2018 |
| MRI characteristics of trigeminal nerve involvement in patients with multiple sclerosis C Swinnen, S Lunskens, O Deryck, J Casselman, L Vanopdenbosch Multiple Sclerosis and Related Disorders 2 (3), 200-203, 2013 | 23 | 2013 |
